Published in Dermatol Surg on August 28, 2012
Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol (2014) 1.03
Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. J Invest Dermatol (2013) 0.84
Skin cancer in organ transplant recipients: more than the immune system. J Am Acad Dermatol (2014) 0.84
Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. J Virol (2014) 0.83
Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review. World J Clin Cases (2014) 0.83
The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study. J Invest Dermatol (2014) 0.82
HPV Type 16 Infection Switches Keratinocytes from Apoptotic to Proliferative Fate under TWEAK/Fn14 Interaction. J Invest Dermatol (2015) 0.80
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report. Biol Blood Marrow Transplant (2016) 0.79
No evidence for integrated viral DNA in the genome sequence of cutaneous squamous cell carcinoma. J Invest Dermatol (2014) 0.77
The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis. Mol Cancer (2015) 0.77
Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. PLoS Pathog (2017) 0.75
Two Cases of Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients with Chronic Human Papillomavirus Infection. Case Rep Dermatol (2015) 0.75
Seroprevalence of Cutaneous Human Papillomaviruses and the Risk of External Genital Lesions in Men: A Nested Case-Control Study. PLoS One (2016) 0.75
Notch as a tumour suppressor. Nat Rev Cancer (2017) 0.75
TWEAK/Fn14 Activation Participates in Skin Inflammation. Mediators Inflamm (2017) 0.75
Classification of papillomaviruses. Virology (2004) 14.16
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Chapter 1: HPV in the etiology of human cancer. Vaccine (2006) 6.61
Papillomaviruses in the causation of human cancers - a brief historical account. Virology (2009) 5.46
Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52
Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med (1997) 4.00
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol (1999) 3.19
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol (2006) 3.13
A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol (1999) 2.99
Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med (1993) 2.91
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40
Immunological events in regressing genital warts. Am J Clin Pathol (1994) 2.37
Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol (2000) 2.36
Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr (2003) 2.32
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Skin cancer in skin of color. J Am Acad Dermatol (2006) 2.23
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation (1990) 2.07
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol (2000) 2.03
Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol (2011) 1.99
Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol (2008) 1.96
Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol (2005) 1.94
Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol (1993) 1.89
Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol (2004) 1.81
Cancer incidence and risk factors after solid organ transplantation. Int J Cancer (2009) 1.78
Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr (2003) 1.67
Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol (2006) 1.61
Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol (2003) 1.58
Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer (1997) 1.58
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis (2007) 1.54
Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol (2006) 1.53
Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51
High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol (2004) 1.48
Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer (2008) 1.46
Seropositivity for human papillomavirus and incidence of subsequent squamous cell and basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Br J Dermatol (2011) 1.45
Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol (2000) 1.44
Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine (2005) 1.43
Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol (2003) 1.42
Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer (2003) 1.41
Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol (2005) 1.38
Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. J Clin Microbiol (2007) 1.36
General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol (2003) 1.33
High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res (2003) 1.32
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol (2006) 1.31
Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res (2010) 1.30
The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol (1996) 1.29
Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol (2006) 1.29
Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol (2008) 1.29
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
HPV DNA detection and typing in cervical scrapes. Methods Mol Med (2005) 1.23
A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.22
Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol (2007) 1.21
The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw (2010) 1.20
Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res (2003) 1.20
Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20
Serological studies in a student population prone to infection with human papilloma virus. J Hyg (Lond) (1972) 1.19
Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ (2010) 1.18
A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol (2003) 1.17
Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer (1994) 1.16
Improved detection of cutaneous human papillomavirus DNA by single tube nested 'hanging droplet' PCR. J Virol Methods (2003) 1.15
Prevention and treatment of papillomavirus-related cancers through immunization. Annu Rev Immunol (2011) 1.15
Papillomaviruses in non-melanoma skin cancer: epidemiological aspects. Semin Cancer Biol (1999) 1.14
Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol (2011) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev (2001) 1.13
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev (2008) 1.12
Human papillomavirus and cervical carcinogenesis. Best Pract Res Clin Obstet Gynaecol (2001) 1.09
Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol (1999) 1.09
Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg (2004) 1.07
Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol (1986) 1.07
Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol (2003) 1.06
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev (2011) 1.05
Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay. J Virol Methods (2010) 1.04
Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol (2008) 1.04
Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol (2009) 1.04
Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J Virol (2008) 1.03
HPV infection and cervical disease: a review. Aust N Z J Obstet Gynaecol (2011) 1.03
Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol (2008) 0.99
Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis. J Gen Virol (2008) 0.99
Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol (2009) 0.97
Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol (2004) 0.96
Can we understand keratoacanthoma? Am J Dermatopathol (2002) 0.96
Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol (2011) 0.96
Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int (2003) 0.94
Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol (2008) 0.92
Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol (2000) 0.92
Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. J Gen Virol (2008) 0.91
Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease. Br J Dermatol (2005) 0.90
Beta-papillomavirus infection and skin cancer. J Invest Dermatol (2008) 0.90
Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med (2012) 6.90
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A (2005) 5.21
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci U S A (2011) 3.10
Temporal dissection of tumorigenesis in primary cancers. Cancer Discov (2011) 2.40
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res (2002) 2.06
Memory regulatory T cells reside in human skin. J Clin Invest (2014) 1.95
Nonmelanoma skin cancer visits and procedure patterns in a nationally representative sample: national ambulatory medical care survey 1995-2007. Dermatol Surg (2013) 1.40
Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med (2003) 1.34
Chemokine receptors and melanoma metastasis. J Dermatol Sci (2004) 1.32
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol (2009) 1.13
Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood (2003) 1.03
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4. Blood (2012) 0.96
IMSA: integrated metagenomic sequence analysis for identification of exogenous reads in a host genomic background. PLoS One (2013) 0.93
Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol (2006) 0.90
Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol (2012) 0.88
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg (2010) 0.85
Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. J Invest Dermatol (2013) 0.84
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant (2012) 0.84
Validity of patient skin cancer report among organ transplant recipients. Clin Transplant (2012) 0.81
Cutting edge in medical management of cutaneous oncology. Semin Cutan Med Surg (2012) 0.78
Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol (2013) 0.78
8S globulin of mungbean [Vigna radiata (L.) Wilczek]: cloning and characterization of its cDNA isoforms, expression in Escherichia coli, purification, and crystallization of the major recombinant 8S isoform. J Agric Food Chem (2004) 0.78
The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J Am Acad Dermatol (2012) 0.77
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis. J Transl Med (2014) 0.75
Antimicrobial Prophylaxis for Full-Face Laser Resurfacing in Transplant Recipients. Dermatol Surg (2017) 0.75
Amicrobial Pustulosis of the Folds and Autoimmunity. J Low Genit Tract Dis (2016) 0.75
Hydraulic expulsion of tumbu fly larvae. JAMA Dermatol (2014) 0.75
Mental Artery Occlusion From Poly-L-Lactic Acid Injection at the Lateral Chin. Dermatol Surg (2017) 0.75